| nivolumab based treatment | pembrolizumab alone |
| nivolumab alone | pembrolizumab (10mg/kg) | pembrolizumab (10mg/kg) 2 weeks | pembrolizumab (2mg/kg) |
| mML - L2 - all population 11 | | | | |
Comparator:
vs Standard of Care (SoC); vs ipilimumab alone;
Risk of bias:
low;
some concerns;
high;
NA;